510(k) Report

510(k) · Cleared

Cleared

Albumin BCG2

K203248510(k) TraditionalCleared Nov 23, 2021384-day reviewClass II21 CFR 862.1035

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Abbott Ireland Diagnostics Division · CIX Bromcresol Green Dye-Binding, Albumin

Cleared on Nov 23, 2021 as substantially equivalent to K981758 (Abbott Laboratories, 1998) after a 384-day review. Its family tree reaches back 2 generations to 1981.

Decided
Nov 23, 2021
Review
384 days
Class
Class II
Product code
CIX
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K811194 (1981). No later device cites it as a predicate yet.

  1. Root · 2 generations backK811194 Hitachi 705 Automatic Blood ChemistryBoehringer Mannheim Corp. · 1981
  2. 1 generation backK981758 ALBGAbbott Laboratories · 1998 · Recalled
  3. This deviceK203248 Albumin BCG2Abbott Ireland Diagnostics Division · 2021
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K811194Hitachi 705 Automatic Blood ChemistryBoehringer Mannheim Corp.1981—
−1K981758ALBGAbbott Laboratories19981
0 (this device)K203248Albumin BCG2Abbott Ireland Diagnostics Division2021—
FIG. 1 — Lineage of K203248, 1981–2021Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CIX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CIX device

  1. #1 K251157 Core Metabolicscore 10.9 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K981758ALBG
Summary page 5
…ion: Class II Classification Name: Albumin test system Governing Regulation Number: 21 CFR 862.1035 Product Code: CIX IV. Predicate Device Albumin BCG (k981758) V. Description of Device Principles of the Procedure The Albumin BCG2 assay is an automated clinical chemistr…
Abbott Laboratories19981

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 40 years and passes through 3 companies; a new generation was cleared every 23.4 years on median.
  • 1 of the 2 ancestors has a recall of any class.

How does its category compare?

All CIX devices

CIX Bromcresol Green Dye-Binding, Albumin: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.

FDA decisions per year · CIX

2in 2021

2007: 12008: 12009: 12011: 32012: 12013: 12018: 12019: 12021: 22026 (partial year): 1
2007high 3 (2011) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CIX

168in 2011

2011: 168 days median
2007high 168 (2011)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CIX

1in 2020

2008: 12010: 12013: 12019: 12020: 1
2007high 1 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CIX

4in 2025

2007: 12010: 742011: 82012: 22016: 12017: 62018: 22020: 12021: 32022: 12023: 42024: 32025: 4
2007high 74 (2010) · low 0 (2008)2025

MAUDE reports naming product code CIX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—01
20081—10
20091—00
20100—174
2011316808
20121—02
20131—10
20140—00
20150—00
20160—01
20170—06
20181—02
20191—10
20200—11
20212—03
20220—01
20230—04
20240—03
20250—04
20261—0—

What is it indicated for?

The Albumin BCG2 assay is used for the quantitation of albumin in human serum or plasma on the ARCHITECT c System.

The Albumin BCG2 assay is to be used as an aid in the diagnosis and treatment of numerous diseases involving primarily the liver or kidneys.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K203248: Albumin BCG2.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K203248

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026